Sanofi SNY

Latest FY: 2025 Healthcare Drug Manufacturers - General
Market Price $42.70
Market Cap $104.14B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑5.5% YoY
$46.72B
3-Yr CAGR: 1.0%
Net Income ↑39.7% YoY
$7.85B
Net Margin: 16.8%
Free Cash Flow ↓-87.5% YoY
$194.00M
FCF Yield: 0.19%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: 6.2%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (SNY)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $34,708.0M $24,006.0M $4,800.0M 0.00% $-2,096.0M
FY 2017 $36,204.0M +4.3% $24,591.0M $8,537.0M +77.9% 0.00% $-1,734.0M $-3,128.0M
FY 2018 $35,677.0M -1.5% $24,242.0M $4,410.0M -48.3% 0.00% $-2,058.0M $-3,517.0M -12.4%
FY 2019 $37,631.0M +5.5% $25,655.0M $2,837.0M -35.7% 0.00% $1,695.0M $434.0M +112.3%
FY 2020 $37,369.0M -0.7% $25,212.0M $12,350.0M +335.3% 0.00% $2,051.0M $741.0M +70.7%
FY 2021 $39,175.0M +4.8% $26,920.0M $6,279.0M -49.2% 0.00% $1,280.0M $-763.0M -203.0%
FY 2022 $45,389.0M +15.9% $31,694.0M $8,484.0M +35.1% 0.00% $2,452.0M $1,689.0M +321.4%
FY 2023 $46,444.0M +2.3% $32,208.0M $5,436.0M -35.9% 0.00% $2,623.0M $524.0M -69.0%
FY 2024 $44,286.0M -4.6% $31,081.0M $5,618.0M +3.3% 0.00% $3,291.0M $1,557.0M +197.1%
FY 2025 $46,716.0M +5.5% $33,667.0M $7,851.0M +39.7% 0.00% $2,885.0M $194.0M -87.5%
$

Valuation

Market Price $42.70
Market Cap $104.14B
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio N/A
FCF Yield 0.19%
Dividend Yield 0.00%
Shares Outstanding 2,438,955,600
%

Profitability & Margins

Gross Margin 72.07%
Operating Margin 13.58%
Net Margin 16.81%
Return on Equity (ROE) N/A
Return on Assets (ROA) 6.19%
Asset Turnover 0.37x
Revenue 3-Yr CAGR 0.97%
🛡️

Financial Health & Liquidity

Current Ratio 0.53
Cash Ratio N/A
Debt / Equity N/A
Debt / Assets 0.000
Cash & Equivalents N/A
Total Debt N/A
Book Value / Share N/A
💧

Cash Flow Efficiency

Operating Cash Flow $2.88B
Capital Expenditures (CapEx) $2.69B
Free Cash Flow $194.00M
OCF / Revenue 6.18%
FCF / Revenue 0.42%
FCF 3-Yr CAGR -51.39%
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share N/A
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $126.81B
Total Liabilities N/A
Stockholders' Equity N/A
Current Assets $397.00M
Current Liabilities $751.00M